Ads
related to: safety, study
Search results
FDA approves Moderna’s RSV vaccine mRESVIA
Pharmaceutical Technology via Yahoo Finance· 4 hours agoFDA approval comes after the successful Phase III ConquerRSV trial, which included 37,000 participants across 22 countries. The study showed an 83.7%...
Studies question hospital operations on tax breaks, service to poor and underinsured
Worcester Telegram & Gazette via Yahoo News· 4 hours agoGarber said that government reimbursements aren't in the report because they don't directly impact...
...Presentation of Clinical Data of A Randomized Controlled Phase 1b Study Evaluating IBI310...
KOIN News 6 Portland· 11 hours ago...Innovent") (HKEX: 01801), a world-class biopharmaceutical company that develops, manufactures and...
ASCO 2024: STORM presents positive interim Phase I data on RNA inhibitor
Clinical Trials Arena via Yahoo Finance· 2 hours agoSTC-15 is an orally bioavailable, small molecule that inhibits METTL3, an RNA methyltransferase...
Structure Posts Positive Topline Results From GSBR-1290 Trials In Obesity; Stock Up In Pre-market
RTT News· 29 minutes agoStructure Therapeutics Inc. (GPCR), a clinical-stage global biopharmaceutical company focused on metabolic and cardiopulmonary diseases, announced Monday positive 12-week topline obesity data ...
Southern US city ranked as worst for deadly car accidents in the country, study says
Fox News via Yahoo News· 1 day agoThe Tennessee city was ranked as the place with the highest rate of deadly car accidents in the...
The top 20 ‘dirtiest’ cities in America, according to study
WPIX New York City, NY via Yahoo News· 13 hours agoThe study analyzed data from various federal agencies, including the Centers for Disease Control and...
Slow down! Where the speed limit has been reduced in Lakewood
FOX 8 Cleveland· 17 minutes agoThe speed limit has changed on a portion of Lake Avenue in Lakewood.
...Therapeutics Announces Efficacy & Safety Result from Phase II Trial...line NSCLC Treatment in...
Fergus Falls Journal· 2 days ago...Therapeutics, a clinical-stage biotechnology company focusing on cutting-edge therapies in oncology and immunology, today announced the phase II trial data of KROCUS Study, fulzerasib (GFH925, KRAS G12C inhibitor) in combination with cetuximab for first-line non-small cell lung cancer (NSCLC)...
Takeda and Pfizer report positive Phase III HD21 trial of ADCETRIS
Clinical Trials Arena via Yahoo Finance· 2 hours agoThe study met its co-primary endpoints at a preplanned three-year analysis, showing significantly...
Ad
related to: safety, study